Finnvera Group’s Report of the Board of Directors and Financial Statements 2021
Finnvera Group, Stock Exchange Release 16 February 2022 Finnvera Group’s Report of the Board of Directors…
4 years ago
Wire Stories
Thailand Prepaid Card and Digital Wallet Business and Investment Opportunities Databook 2022 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Thailand Prepaid Card and Digital Wallet Business and Investment Opportunities Databook - Market…
4 years ago
Innovation: The Key to VOOPOO’s Leapfrog Development
SHENZHEN, China--(BUSINESS WIRE)--VOOPOO, a leading vape manufacturer, recently released a review on its development, revealing…
4 years ago
Drone Racing League Algorand World Championship Race Highlights Successful Season for Draganfly
Los Angeles, CA., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO)…
4 years ago
Visteon Announces 2021 Financial Results and 2022 Outlook
VAN BUREN TOWNSHIP, Mich., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Visteon Corporation (NASDAQ: VC) today…
4 years ago
Radware Announces a Strategic Initiative to Accelerate the Growth of its Cloud Security Services Business
Acquires SecurityDAM, and expands its innovation center, cloud services division, and its cloud network footprint…
4 years ago
Tower Semiconductor Reports 2021 Fourth Quarter and Full Year Financial Results
MIGDAL HAEMEK, Israel, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Tower Semiconductor (NASDAQ: TSEM & TASE:…
4 years ago
NOHO PARTNERS PLC’S FINANCIAL STATEMENTS RELEASE 1 JANUARY–31 DECEMBER 2021: Operating loss for 2021 was MEUR 0.9 – the fourth quarter’s EBIT rose to a record-breaking level
NoHo Partners PlcFINANCIAL STATEMENTS RELEASE 17 February 2022 at 8:15NOHO PARTNERS PLC’S FINANCIAL STATEMENTS RELEASE…
4 years ago
Netcracker Wins Fierce Innovation Award for BSS/OSS
Award Recognizes Netcracker Digital BSS/OSS for Helping CSPs Optimize 5G with Converged Charging and Cloud-Native…
4 years ago
ACTG and Shionogi Announce Progress on Global Phase 3 Trial of Novel COVID-19 Oral Antiviral Agent S?217622
FDA has cleared the IND for S-217622, a once-daily investigational oral antiviral therapy, enabling the…
4 years ago